SCHEMBL7472682

SCHEMBL7472682

CC1=NC(C)(c2cc[c]cc2)C=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6623764 0.63 SLC6A2 (0.39)
Hydrochloric Acid SCHEMBL8461636 0.61
SCHEMBL5833030 0.61
SCHEMBL2649526 0.60
Hydrochloric Acid SCHEMBL9410202 0.60
Hydrochloric Acid SCHEMBL9410186 0.60
SCHEMBL664080 0.58
SCHEMBL16919350 0.58 ALDH1A1 (0.33)
SCHEMBL2006920 0.57
SCHEMBL1814521 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0937708-B1 Sulphonamide derivatives LILLY CO ELI (US) 2002-12-18 EP claimed
US-6362230-B1 ALZHEIMER'S DISEASE ELI LILLY AND COMPANY 2002-03-26 US claimed
US-6174922-B1 FOR POTENTIATING GLUTAMATE RECEPTOR FUNCTION IN WARM BLOODED MAMMAL ELI LILLY AND COMPANY 2001-01-16 US claimed
EP-0937708-A2 sulphonamide derivatives ELI LILLY AND COMPANY (US) 1999-08-25 EP claimed
EP-0937708-B1 Sulphonamide derivatives LILLY CO ELI (US) 2002-12-18 EP disclosed
US-6362230-B1 ALZHEIMER'S DISEASE ELI LILLY AND COMPANY 2002-03-26 US disclosed
US-6174922-B1 FOR POTENTIATING GLUTAMATE RECEPTOR FUNCTION IN WARM BLOODED MAMMAL ELI LILLY AND COMPANY 2001-01-16 US disclosed
EP-0937708-A2 sulphonamide derivatives ELI LILLY AND COMPANY (US) 1999-08-25 EP disclosed